Torrence P F, Kinjo J, Lesiak K, Balzarini J, De Clercq E
Section on Biomedical Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892.
FEBS Lett. 1988 Jul 4;234(1):135-40. doi: 10.1016/0014-5793(88)81319-x.
In an attempt to provide a derivative of 3'-azido-3'-deoxythymidine (AZT) which might be sequestered in the central nervous system and release AZT, the dihydropyridine ester 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-deoxythymidine, was synthesized in a three step sequence. This material showed potent anti-HIV-1 activity in MT-4 cells most probably by hydrolysis to the parent nucleoside, AZT. This dihydropyridine derivative of AZT could be easily oxidized to a positively charged pyridinium derivative of AZT in rat brain cytosol. In turn the pyridinium form could be hydrolyzed, non-enzymatically, to AZT.